Meershoek A, Zwerling A, Daftary A, Citro B, Smyth C, Lewis D
1
Meierhofer, R
1
Melvyn Freeman, Michelle Funk, Soumitra Pathare et al.
1
Mental Health America
1
Mental Health Improvements for Nations Development (MIND)
1
Meyer, S.
1
Médecins sans Frontières MSF
1
Minister of Health & Social Welfare (MoHSW), Kingdom of Lesotho
1
Minister of Health Republic of Indonesia
1
Ministerio de salud pública y bienestar social, Paraguay
1
Ministerio de Salud y Deportes (MSD)
1
Ministère de la Santé Publique et de la Population (M.S.P.P.)
1
Ministry of Law and Justice (Legislative Department), India
1
Ministry of Agricultur al Development (MOAD)
1
Ministry of Education, Rwanda
1
Ministry of Gender, Labour & Social Development, Uganda
1
Ministry of Health & Ministry of Local Government, Gabarone, Botswana
1
Ministry of Health & Sanitation, Sierra Leone
1
Ministry of Health and Child Care & UNICEF
1
Ministry of Health and Family Welfare Government of India
1
Ministry of Health and Family Welfare Government of the People's Republic of Bangladesh
1
Ministry of Health and Family Welfare, Bangladesh
1
Ministry of Health and Population, Nepal
1
Ministry of Health and Sanitation, International Centre for Eye Health, Sightsavers
1
Ministry of Health and Sanitaton Sierra Leone and UNICEF Sierra Leone
1
Ministry of Health and Social Services (MOHSS) & Ministry of Education, Arts and Culture (MOEAC)
1
Ministry of Health and Social Services, Namibia
1
Ministry of Health and Social Welfare (MoHSW), Kingdom of Lesotho
1
Ministry of Health and Social Welfare, Dar es Salaam, Ministry of Health, Zanzibar, National Bureau of Statistics, Zanzibar, Tanzania, and ICF International
1
Ministry of Health and Social Welfare, Government of Lesotho
1
Ministry of Health and Social Welfare, Republic of Liberia
1
Ministry of Health Republic of Indonesia, WHO
1
Ministry of Health Zambia
1
Ministry of Health, Community Development, Gender, Elderly and Children (MoHCDGEC), [Tanzania Mainland, Ministry of Health (MoH) [Zanzibar], National Bureau of Statistics (NBS), Office of the Chief Government Statistician (OCGS) and ICF.
1
Ministry of Health, Ghana, World Health Organizaiotn (WHO) and Ghana Health Service
1
Ministry of Health, Kingdom of Lesotho
1
Ministry of Health, Liberia
1
Ministry of Health, Republic of Liberia
1
Ministry of Health, Rwanda
1
Ministry of Health, Rwanda & Rwanda Biomedical Centre
1
Ministry of Health, South Africa
1
Ministry of Health, Tanzania
1
Ministry of Health, Zambia, et al.
1
Ministry of Labour and Employment, Government of India
1
Ministry of Public Health, Cameroon
1
Minos Mouzourakis, Kris Pollet, Ruben Fierens
1
Misereor
1
Mohammed Kabir, Zubair Iliyasu, Isa S Abubakar & Muktar H Aliyu
1
MRC South Africa
1
Mujaddid
1
Multicultural Mental Health Australia
1
N. Drew
1
N. Isberner
1
N. N. Fido
1
N. Nguyen
1
N. Tohnain, E. Tamajong
1
NAD
1
NADMO Ghana
1
Nana Wiedemann, Birgitte Sloth Yigen, Sara Johansson, et al.
1
National Academies of Sciences, Engineering, and Medicine
1
National AIDS Commission Liberia
1
National AIDS Control Organization (NACO), Ministry of Health and Family Welfare, Government of India
1
National Center for Tuberculosis and Leprosy Control, Cambodia
1
National Grassroots and Disabilities Organization (NGDO), National Council for Women with Disabilities (NCDW), Bangladesh Legal Aid and Services Trust (BLAST)
1
National health Mission
1
National HIV
1
National HIV/AIDS/STI/TB Council
1
National Malaria Elimination Centre, Ministry of Health, Zambia
1
National Planning Commission (NPC), Government of Nepal, Central Bureau of Statistics (CBS), et al.
1
National Primary Health Care Development Agency
1
National Reproductive Health Programme Ministry of Health
1
National Union of Disabled Persons of Uganda (NUDIPU)
1
NDP 2030
1
Nepal Health Research Council
1
Nepal Ministry of Health and Population, New ERA, and ICF International
1
Neuron Review
1
NFD-N (National federation of the disabled- Nepal)
1
NFPA, UNDESA, UN-HABITAT, IOM
1
Nidhi Singal
1
Norwegian Refugee Council
1
Novel Psychoactive Treatment UK Network (NEPTUNE)
1
NRSAD (National Religious Association for Social Development)
1
Nurcombe, B.
1
Nurkhayani, E., E. Setyowati and Y.H. Sandyatma
1
O. Aderomilehin
1
O. O. Ozoya
1
Office for the Coordination of Humanitarian Affairs OCHA
1
Okular Analystis, EU
1
Olivia Tiberi
1
Ombok, C.A., Obondo, A., Kangethe, R. & Atwoli, L.
1
Open Society Institute - Public Health Program
1
Organisation for Economic Co-operation and Development (OECD)
1
Organización Mundial de la Salud OMS
1
Organización Panamericana de la Salud
1
Organizaición Mundial de la Salud
1
Overseas Development Institute (ODI),
1
P. Brouwers
1
P. J. de Vries
1
P. Korpinen
1
P. Kruger
1
P. Monfiston
1
P. Ozório
1
P. T. Fernandes
1
Paget Stanfield, Martin Brueton, Michael Chan, Michael Parkin, and Tony Waterston
1
PAHO
1
Pan American Health Organization (Regional Office of the World Health Organization)
1
Patel V, Simon G, Chowdhary N, Kaaya S, Araya R
1
Patricio V. Marquez, and Shekhar Saxena
1
Patrick Smith, T. Dalgleish and R. Meiser‐Stedman
1
Patrick Vinck ,Phuong Pham
1
Patrick, S., Perrin, S., Tim, D., Richard, M-S., David M, C., & William, Y.
1
Pazan, F.
1
Persaud, C.
1
Philippine Society for Microbiology and Infectious Diseases
1
Philippine Society for Microbiology and Infectious Diseases, Philippine College of Chest Physicians, Philippine Academy of Family Physicians
1
Philipps,J.A., et al.
1
Pia Korpinen
1
Plan
1
Plan International
1
PMC (US National Library of Medicine National Institutes of Health)
Caring for burns patients from the incident scene to definitive treatment can be a complex, resource-consuming process with the potential to overwhelm health system capacity.This document provides practical guidance for building capacity and capability for burns care from clinical, human resources a...nd operational perspectives. It is therefore recommended that guidance in this document be applied to any contexts in which the local health system might struggle to cope and require surge support.more
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys...tems to anticipate and mitigate stresses across NCD medicine supply chains. The full range of upstream and downstream impacts are investigated, including: manufacturing; procurement, importation and last mile delivery; patient-level effects through affordability and availability; and the effects on NCD medicine availability by category of disease. The report culminates in recommended actions and interventions for key stakeholders in the NCD pharmaceutical supply chain, including governments, regulatory authorities, manufacturers and the private sector; as well as directions for future research for improving access and supply chain access resilience.more
The Regional Action Framework for Noncommunicable Disease Prevention and Control provides a unified vision of objectives and recommended actions to combat the noncommunicable disease (NCD) epidemic in the Western Pacific Region. Implementation should be supported by cross-sectoral coordination..., sustainable financing, evidence-based policy, and community engagement, tailored to each Member State’s unique context. In doing so, Member States are encouraged to transform a disease treatment-centered “sick system” into a “health system” in which a population’s health and well-being enable socioeconomic development.more
The KMC implementation strategy targets a broad audience. These include policy-makers and programme managers at national, regional and local levels, government and nongovernmental organizations working in the area of maternal and newborn care, global and national professional associations, public an...d private hospital management at all levels of care, and facility- and community-based maternal and infant care providers.more
Q7. SCOPING QUESTION: In adults with moderate-severe depressive disorder, what is the effectiveness and safety of antidepressant medication (ADM) in comparison with psychological treatment?
The WHO mhGAP programme’s existing guidelines recommend that either structured brief psychological treatm...ents (e.g., interpersonal psychotherapy or cognitive behavioural therapy, including behavioural activation) or antidepressant medication (e.g., SSRIsi and tricyclic antidepressants) be considered in adults with moderate-severe depression. Health care workers need to know whether these treatments have different effects, including side-effects, in treating depressive disorder in the short and long term, in order to improve clinical decision-making.more
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys...tems to anticipate and mitigate stresses across NCD medicine supply chains. The full range of upstream and downstream impacts are investigated, including: manufacturing; procurement, importation and last mile delivery; patient-level effects through affordability and availability; and the effects on NCD medicine availability by category of disease. The report culminates in recommended actions and interventions for key stakeholders in the NCD pharmaceutical supply chain, including governments, regulatory authorities, manufacturers and the private sector; as well as directions for future research for improving access and supply chain access resilience.more
Report of the WHO/Bill & Melinda Gates Foundation Consultation. The Consultation was organized back-to-back with the first annual meeting of the International Coordinating Group of the BMGF-funded project for human and dog rabies elimination in developing countries, held at WHO headquarters, Geneva,... Switzerland, from 5 to 7 October 2009. This allowed the Consultation to benefit from the participation of the national coordinators and advisers of the BMGF-funded projects in the Philippines, South Africa (KwaZulu-Natal) and the United Republic of Tanzaniamore
Since 2000, concerted efforts by national programmes, supported by public–private partnerships, nongovernmental organizations, donors and academia under the auspices and coordination of the World Health Organization (WHO), have produced important achievements in the control of human African trypan...osomiasis (HAT). As a consequence, the disease was targeted for elimination as a public health problem by 2020. The Sixty-sixth World Health Assembly endorsed this goal in resolution WHA66.12 on neglected tropical diseases, adopted in 2013.
National sleeping sickness control programmes (NSSCPs) are core to progressing control of the disease and in adapting to the different epidemiological situations. The involvement of different partners, as well as the support and trust of long-term donors, has been crucial for the achievements.more
These guidelines group all recommendations on TB care and support in one document and are complemented by an operational handbook. The guidelines are to be used primarily by national TB programmes, or their equivalents in Ministries of Health, stakeholders and technical organizations working on... TB care in the public and private sectors and in the community.more
These WHO interim recommendations on the use of the Astra Zeneca – Oxford University AZD1222 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenc...ed below.
This document has been updated: Version 15 March 2022.more
This second edition of the Infection prevention and control in the context of coronavirus disease (COVID-19): A living guideline provides the most up to date technical guidance on mask use in community settings in the context of COVID-19.
In this edition, new information includes updated mask re...commendations for children in community settings including updated age specific recommendations, statements for children with disabilities and those at high risk for complications related to COVID-19 infection. Updated implementation considerations for mask use in school settings are also included.
This living guideline is being published using the MAGICApp online publishing platform https://app.magicapp.org/#/guideline/Lr2a8L , as well as in PDF copy on the WHO website.more